The Cytochrome P450 System, Reactive Oxygen Species and Cellular Ageing: Molecular Mechanisms, Pharmacological Implications and Clinical Management in Frail Older Adults
Authors/Creators
Description
The cytochrome P450 (CYP450) system mediates the biotransformation of 70–80% of all clinically used drugs and is an obligate source of reactive oxygen species (ROS) through catalytic uncoupling. With ageing, CYP450 activity declines heterogeneously—most notably CYP3A4, by an estimated 30–50% in adults over 70 years—in the context of reduced hepatic mass, sinusoidal blood flow, and progressive pseudocapillarisation. The frail older adult compounds this age-related decline with inflammaging-driven CYP450 suppression and nutritional depletion of antioxidant cofactors, constituting a 'triple pharmacological penalisation syndrome'. Microsomal ROS may contribute—through well-characterised molecular mechanisms—to hallmarks of cellular ageing including genomic instability, telomere shortening, proteostasis failure, mitochondrial dysfunction, and cellular senescence. Whilst direct causal demonstration in humans remains methodologically challenging, this mechanism represents a potentially modifiable dimension of pharmacological vulnerability in frail older patients. This review integrates mechanistic, pharmacokinetic, and clinical evidence with explicit evidence grading, an expanded high-risk drug table with clinical alerts and safer alternatives, and a three-level clinical algorithm applicable across healthcare settings. Key messages include the need to limit paracetamol to ≤2 g/day in frail malnourished patients, to avoid long-acting benzodiazepines in favour of glucuronidation-pathway alternatives, and to substitute CYP3A4-dependent statins when potent inhibitors are co-prescribed. Pharmacogenomic testing, as demonstrated in the PREPARE trial, holds promise for ADR reduction but requires cost-effectiveness evidence in geriatric populations before universal implementation
Files
CYP450_prepint.pdf
Additional details
Additional titles
- Translated title (Spanish)
- El sistema del citocromo P450, las especies reactivas del oxígeno y el envejecimiento celular: mecanismos moleculares, implicaciones farmacológicas y manejo clínico en personas mayores frágiles
Dates
- Submitted
-
2026-06-02Critical narrative review examining the biochemical relationships between nutritional cofactors and the cytochrome P450 (CYP450) enzyme system, with specific focus on geriatric pharmacology. The review systematically analyzes the evidence for B vitamins (riboflavin, niacin, pyridoxine), glutathione, selenium, and associated micronutrients as essential cofactors for CYP450 function and antioxidant protection. Using a GRADE-adapted evidence grading system, the manuscript distinguishes between: (a) mechanistic evidence of essential cofactor roles—biochemically indisputable; (b) clinical evidence that deficiency correction restores CYP450 function; and (c) absence of evidence that supplementation in nutritionally sufficient individuals improves drug metabolism. Key findings include documentation of age-related decline in hepatic glutathione (20-40% reduction), high prevalence of micronutrient deficiencies in institutionalized elderly (10-60% depending on nutrient), and potential for targeted nutritional interve